7 resultados para EVALITA 2009
em Indian Institute of Science - Bangalore - Índia
Resumo:
The Indian summer monsoon season of 2009 commenced with a massive deficit in all-India rainfall of 48% of the average rainfall in June. The all-India rainfall in July was close to the normal but that in August was deficit by 27%. In this paper, we first focus on June 2009, elucidating the special features and attempting to identify the factors that could have led to the large deficit in rainfall. In June 2009, the phase of the two important modes, viz., El Nino and Southern Oscillation (ENSO) and the equatorial Indian Ocean Oscillation (EQUINOO) was unfavourable. Also, the eastern equatorial Indian Ocean (EEIO) was warmer than in other years and much warmer than the Bay. In almost all the years, the opposite is true, i.e., the Bay is warmer than EEIO in June. It appears that this SST gradient gave an edge to the tropical convergence zone over the eastern equatorial Indian Ocean, in competition with the organized convection over the Bay. Thus, convection was not sustained for more than three or four days over the Bay and no northward propagations occurred. We suggest that the reversal of the sea surface temperature (SST) gradient between the Bay of Bengal and EEIO, played a critical role in the rainfall deficit over the Bay and hence the Indian region. We also suggest that suppression of convection over EEIO in association with the El Nino led to a positive phase of EQUINOO in July and hence revival of the monsoon despite the El Nino. It appears that the transition to a negative phase of EQUINOO in August and the associated large deficit in monsoon rainfall can also be attributed to the El Nino.
Resumo:
We performed high resolution spectroscopy of the solar corona during the total solar eclipse of 22 July 2009 in two emission lines: the green line at 5303 due to Fe xiv and the red line at 6374 due to Fe x, simultaneously from Anji (latitude 30A degrees 28.1' N; longitude 119A degrees 35.4' E; elevation 890 m), China. A two-mirror coelostat with 100 cm focal length lens produced a 9.2 mm image of the Sun. The spectrograph using 140 cm focal length lens in Littrow mode and a grating with 600 lines per millimeter blazed at 2 mu m provided a dispersion of 30 m and 43 m per pixel in the fourth order around the green line and third order around the red line, respectively. Two Peltier cooled 1k x 1k CCD cameras, with a pixel size of 13 mu m square and 14-bit readout at 10 MHz operated in frame transfer mode, were used to obtain the time sequence spectra in two emission lines simultaneously. The duration of totality was 341 s, but we could get spectra for 270 s after a trial exposure at an interval of 5 s. We report here on the detection of intensity, velocity, and line width oscillations with periodicity in the range of 25 -50 s. These oscillations can be interpreted in terms of the presence of fast magnetoacoustic waves or torsional Alfv,n waves. The intensity ratios of green to red emission lines indicate the temperature of the corona to be 1.65 MK in the equatorial region and 1.40 MK in the polar region, relatively higher than the expected temperature during the low activity period. The width variation of the emission lines in different coronal structures suggests different physical conditions in different structures.
Resumo:
Background: There was a low adherence to influenza A (H1N1) vaccination program among university students and health care workers during the pandemic influenza in many parts of the world. Vaccination of high risk individuals is one of the recommendations of World Health Organization during the post-pandemic period. It is not documented about the student's knowledge, attitude and willingness to accept H1N1 vaccination during the post-pandemic period. We aimed to analyze the student's knowledge, attitude and willingness to accept H1N1 vaccination during the post-pandemic period in India. Methods: Vaccine against H1N1 was made available to the students of Vellore Institute of Technology, India from September 2010. The data are based on a cross-sectional study conducted during October 2010 to January 2011 using a self-administered questionnaire with a representative sample of the student population (N = 802). Results: Of the 802 respondents, only 102/802 (12.7%) had been vaccinated and 105/802 (13%) planned to do so in the future, while 595/802 (74%) would probably or definitely not get vaccinated in the future. The highest coverage was among the female (65/102, 63.7%) and non-compliance was higher among men in the group (384/595; 64.5%) (p < 0.0001). The representation of students from school of Bio-sciences and Bio-technology among vaccinees is significantly higher than that of other schools. Majority of the study population from the three groups perceived vaccine against H1N1 as the effective preventive measure when compared to other preventive measures. 250/595 (42%) of the responders argued of not being in the risk group. The risk perception was significantly higher among female (p < 0.0001). With in the study group, 453/802 (56.4%) said that they got the information, mostly from media. Conclusions: Our study shows that the vaccination coverage among university students remains very low in the post-pandemic period and doubts about the safety and effectiveness of the vaccine are key elements in their rejection. Our results indicate a need to provide accessible information about the vaccine safety by scientific authorities and fill gaps and confusions in this regard.
Resumo:
Influenza virus evades host immunity through antigenic drift and shift, and continues to circulate in the human population causing periodic outbreaks including the recent 2009 pandemic. A large segment of the population was potentially susceptible to this novel strain of virus. Historically, monoclonal antibodies (MAbs) have been fundamental tools for diagnosis and epitope mapping of influenza viruses and their importance as an alternate treatment option is also being realized. The current study describes isolation of a high affinity (K-D = 2.1 +/- 0.4 pM) murine MAb, MA2077 that binds specifically to the hemagglutinin (HA) surface glycoprotein of the pandemic virus. The antibody neutralized the 2009 pandemic H1N1 virus in an in vitro microneutralization assay (IC50 = 0.08 mu g/ml). MA2077 also showed hemagglutination inhibition activity (HI titre of 0.50 mu g/ml) against the pandemic virus. In a competition ELISA, MA2077 competed with the binding site of the human MAb, 2D1 (isolated from a survivor of the 1918 Spanish flu pandemic) on pandemic H1N1 HA. Epitope mapping studies using yeast cell-surface display of a stable HA1 fragment, wherein `Sa' and `Sb' sites were independently mutated, localized the binding site of MA2077 within the `Sa' antigenic site. These studies will facilitate our understanding of antigen antibody interaction in the context of neutralization of the pandemic influenza virus.
Resumo:
The 2009 pandemic H1N1 S-OIV (swine origin influenza A virus) caused noticeable morbidity and mortality worldwide. In addition to vaccine and antiviral drug therapy, the use of influenza virus neutralizing monoclonal antibodies (MAbs) for treatment purposes is a viable alternative. We previously reported the isolation of a high affinity, potently neutralizing murine MAb MA2077 against 2009 pandemic H1N1 virus. We describe here the humanization of MA2077 and its expression in a mammalian cell line. Six complementarity-determining regions (CDRs) of MA2077 were grafted onto the human germline variable regions; along with six and eight back mutations in the framework of heavy and light chains, respectively, pertaining to the vernier zone and interchain packing residues to promote favorable CDR conformation and facilitate antigen binding. The full length humanized antibody, 2077Hu2, expressed in CHO-K1 cells, showed high affinity to hemagglutinin protein (K-D = 0.75 +/- 0.32 nM) and potent neutralization of pandemic H1N1 virus (IC50 = 0.17 mu g/mL), with marginally higher IC50 as compared to MA2077 (0.08 mu g/mL). In addition, 2077Hu2 also retained the epitope specificity for the ``Sa'' antigenic site on pandemic HA. To the best of our knowledge, this is the first report of a humanized neutralizing antibody against pandemic H1N1 virus.